NEWARK, N.Y.--(BUSINESS WIRE)--Feb. 8, 2008--Ultralife (NASDAQ: ULBI) announced that it has entered into a definitive agreement to form a joint venture with its distribution partner in India to establish a battery assembly and sales operation in Bangalore.

The joint venture company, of which Ultralife will own 51%, has received approval by the Indian government and will be managed locally by Ultralife's partner, Mr. B. R. Ganesh. The joint venture company will assemble Ultralife power solution products and manage local sales and marketing activities, serving commercial, government and defense customers throughout India.

"This venture enables us to deepen our presence in the rapidly growing market in India, thus facilitating access to a diverse set of customers throughout the country," said John D. Kavazanjian, Ultralife's president and chief executive officer. "Although we will initially focus on the sale of battery products, we have the option to broaden the operation to support the assembly and sale of a wider range of power solutions."

About Ultralife

Ultralife, which began as a battery company, now offers products and services ranging from portable and standby power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Ultralife's family of brands includes: Ultralife Batteries, Stationary Power Services, Reserve Power Systems, ABLE, McDowell Research and RedBlack Communications. Ultralife's operations are in North America, Europe and Asia. For more information, visit www.ulbi.com.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: Addressing the process of U.S. military procurement, worsening global economic conditions, increased competitive environment and pricing pressures, disruptions related to restructuring actions and delays. Further information on these factors and other factors that could affect Ultralife's financial results is included in Ultralife's Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

CONTACT:
Ultralife
Pete Comerford, 315-332-7100
pcomerford@ulbi.com

Investor Relations:
Lippert/Heilshorn & Associates, Inc.
Jody Burfening, 212-838-3777
jburfening@lhai.com